MA
BMRN icon

MUFG Americas’s BioMarin Pharmaceuticals BMRN Stock Holding History

MUFG Americas’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,486
Closed -$805K – 91
2022
Q3 		$805K Sell
9,486
-318
-3% -$28.3K 0.02% 270
2022
Q2 		$812K Sell
9,804
-364
-4% -$29K 0.02% 277
2022
Q1 		$783K Buy
10,168
+258
+3% +$21.6K 0.02% 282
2021
Q4 		$875K Sell
9,910
-7,336
-43% -$605K 0.02% 281
2021
Q3 		$1.33M Sell
17,246
-880
-5% -$69.4K 0.02% 247
2021
Q2 		$1.51M Buy
18,126
+1,772
+11% +$140K 0.02% 237
2021
Q1 		$1.24M Buy
16,354
+6,875
+73% +$562K 0.02% 263
2020
Q4 		$831K Buy
9,479
+2,104
+29% +$167K 0.01% 293
2020
Q3 		$561K Sell
7,375
-1,949
-21% -$197K 0.01% 303
2020
Q2 		$1.15M Buy
9,324
+1,309
+16% +$130K 0.03% 250
2020
Q1 		$677K Buy
8,015
+1,662
+26% +$143K 0.02% 277
2019
Q4 		$537K Buy
6,353
+4,932
+347% +$373K 0.01% 327
2019
Q3 		$96K Buy
1,421
+1,215
+590% +$93.6K ﹤0.01% 462
2019
Q2 		$18K Buy
+206
New +$17.6K ﹤0.01% 653
2014
Q3 		– Sell
-37
Closed -$2K – 1299
2014
Q2 		$2K Sell
37
-28
-43% -$1.69K ﹤0.01% 1084
2014
Q1 		$4K Buy
+65
New +$4.79K ﹤0.01% 985
2013
Q3 		– Sell
-4,000
Closed -$223K – 1202
2013
Q2 		$223K Buy
+4,000
New +$249K ﹤0.01% 860

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

MUFG Americas's BMRN Position: Q4 2022 in Review

MUFG Americas sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2022, closing a stake of 9,486 shares — an estimated $805K sold.

MUFG Americas first reported a position in BMRN in Q2 2013 and held it in 17 quarters. The position peaked at $1.51M in Q2 2021. 580 funds tracked by Wall St. Rank hold BMRN as of Q4 2022.

  • MUFG Americas reported no remaining BioMarin Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • MUFG Americas sold 9,486 BioMarin Pharmaceuticals shares in Q4 2022, an estimated $805K.
  • MUFG Americas first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • MUFG Americas's BioMarin Pharmaceuticals position peaked at $1.51M in Q2 2021.
  • 580 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2022.

Based on MUFG Americas's 13F filing for Q4 2022.